3

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: October 11, 2023
Period of Report: October 9, 2023
Accession Number: 0001127602-23-025763

View Document ↗ View on SEC.gov ↗